Rescuing the heart: HIET in undifferentiated shock from beta-blocker and dapagliflozin overdose in acute coronary syndrome
Open Access
- 14 February 2025
- journal article
- Published by Elsevier in JEM Reports
- Vol. 4 (1)
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Hypoglycemia Risk With SGLT2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists Versus Sulfonylureas Among Medicare Insured Adults With CKD in the United StatesKidney Medicine, 2022
- Pharmacologic Management for Ventricular Arrhythmias: Overview of Anti-Arrhythmic DrugsJournal of Clinical Medicine, 2022
- Towards appropriate polypharmacy in older cardiovascular patients: How many medications do I have to take?Clinical Cardiology, 2019
- Effect of Dapagliflozin Treatment on Fluid and Electrolyte Balance in Diabetic RatsThe American Journal of the Medical Sciences, 2016
- Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task forceEuroIntervention, 2015
- High dose insulin therapy, an evidence based approach to beta blocker/calcium channel blocker toxicityDARU Journal of Pharmaceutical Sciences, 2014
- Relative safety of hyperinsulinaemia/euglycaemia therapy in the management of calcium channel blocker overdose: a prospective observational studyIntensive Care Medicine, 2007
- Management of β-Adrenergic Blocker and Calcium Channel Antagonist ToxicityEmergency Medicine Clinics of North America, 2007